TickerFacts.

Nuo Therapeutics, Inc. (AURX): R&D Expense

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2014-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest R&D Expense is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$0
Year ended 2021-12-31
$4.04M2010-12-31: $415.6K2011-12-31: $98.1K2012-12-31: $3.39M2013-12-31: $3.80M2014-12-31: $4.04M2015-12-31: $2.55M2017-12-31: $1.33M2018-12-31: $576.2K2019-12-31: $181.2K2020-12-31: $02021-12-31: $0$0
2010-12-31 R&D Expense (USD) 2021-12-31
Period endedR&D ExpenseChange YoYSource filing
2021-12-31$0n/a2022-04-15, From 2021-01-01
2020-12-31$0-100.0%2022-04-15, From 2020-01-01
2019-12-31$181.2K-68.6%2022-04-15, From 2019-01-01
2018-12-31$576.2K-56.6%2019-04-16, From 2018-01-01
2017-12-31$1.33Mn/a2019-04-16, From 2017-01-01
No annual figure between 2015-12-31 and 2017-12-31.
2015-12-31$2.55M-36.8%2016-10-24, From 2015-01-01
2014-12-31$4.04Mn/c2016-10-24, From 2014-01-01
2013-12-31$3.80M+12.2%2015-03-31, From 2013-01-01
2012-12-31$3.39Mn/m2014-03-31, From 2012-01-01
2011-12-31$98.1K-76.4%2013-03-18, From 2011-01-01
2010-12-31$415.6Kn/a2012-03-29, From 2010-01-01